A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)
NCT06817382
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Duchenne Muscular Dystrophy
Interventions
GENETIC:
INS1201
Sponsor
Insmed Gene Therapy LLC